In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
- Resource Type
- Authors
- Duha Ilyas; Tasnim Momoniat; Sunil Bhandari
- Source
- Cleveland Clinic Journal of Medicine. 87:9.2-10
- Subject
- 03 medical and health sciences
0302 clinical medicine
business.industry
Diabetes mellitus
Renin–angiotensin system
Medicine
Angiotensin II Receptor Blockers
030212 general & internal medicine
General Medicine
Extremely Helpful
Pharmacology
business
medicine.disease
- Language
- ISSN
- 1939-2869
0891-1150
We would like to thank Dr. Fakheri and colleagues for their extremely helpful comments on our recent review of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs).[1][1] We agree entirely with their suggestion on the lack of current data on any superiority of